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Dr. Nathan Boonstra Honored as Iowa’s Childhood Immunization Champion 
The Centers for Disease Control and Prevention (CDC) Childhood Immunization 
Champion Award, given jointly by the CDC and the CDC Foundation, honors 
individuals who are doing an exemplary job or going above and beyond to promote or 
foster childhood immunizations in their communities.  
 
Dr. Nathan Boonstra is honored as Iowa’s 2014 CDC Childhood Immunization 
Champion. 
 
Dr. Nathan Boonstra solidified a 90% vaccination rate at his clinic and fellow 
physicians share he takes as much time as needed to educate his vaccine-hesitant 
parents to help them be comfortable with their decision, often providing his email 
address so he can directly address links to websites with questionable information.   
He routinely speaks to parent groups in the area on the importance of infant vaccinations and their safety.  Dr. 
Boonstra is viewed as the go-to expert on immunization education at Blank Children's Hospital in Des Moines. 
 
He developed material for new parents at Blank Children's Pediatric clinic outlining the clinic's strong 
recommendation of vaccines, and providing reputable resources for further information.  He speaks 
frequently about infant vaccines during weekly morning radio segments aired on two area stations and has 
done a local public service television spot on influenza vaccination.  Dr. Boonstra covers the immunization 
education for medical students who rotate through Blank Children's Hospital with a monthly interactive 
didactic lecture, with focus on common vaccine myths and how to address them. 
 
He is a strong Iowa voice for the pro-vaccine movement given his expertise and use of social media as well as 
traditional media.  Dr. Boonstra uses social media to advocate for immunizations, authored a blog post on the 
importance of the HPV vaccine for the non-profit, parent-led organization Voices for Vaccines 
(www.voicesforvaccines.org/hpv-vaccines-and-failure-to-communicate/), and has collaborated with the Iowa 
Immunization Coalition, Iowa Cancer Consortium, Iowa Department of Public Health, and Iowa Public Health 
Association to produce literature directed towards Iowa health care providers on the importance of the 
prevention of cancers with the HPV vaccine.  
 
Dr. Boonstra’s steadfast commitment to preventing disease in children through leadership, education, and 
advocacy is what makes him a model immunization partner for the state, his medical system, the community 
and his patients.  Dr. Boonstra truly is a Childhood Immunization Champion. 
 
The Iowa Immunization Program received numerous applications for the Immunization Champion Award.  The 
following individuals were nominated for the 2014 Immunization Champion Award by their peers:  Nancy 
Achenbach - Iowa County Health Department; Julie Bruck - Myrtue Medical Center; Stacy Crill - Keokuk County 
Medical Center; Delma Hardin - Delaware County Public Health; Thane Kading, - Hy-Vee Pharmacy; Becky 
Langreck - Winneshiek Medical Center; Maria Mathis - Mercy Medical Center North Iowa; Cheri Schmit, 
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Medical - GRX Holdings; Dr. Joshua Stubblefield - Broadlawns Medical Center; and Michelle Teberg - Unity 
Point St. Luke’s.  We would like to congratulation all nominees and thank them for their work and dedication 
to promoting immunizations in Iowa.  
 
 
 
 
We would like to congratulate and acknowledge the following Iowa hospitals for their inclusion into the 
Immunization Action Coalition’s (IAC’s) Hepatitis B Birth Dose Honor Roll: 
 Myrtue Medical Center, Harlan, IA 
o Reported a coverage rate of 94% from 7/1/2012 to 6/30/2013 
 Greene County Medical Center, Jefferson, IA 
o Reported a coverage rate of 100% from 11/1/2012 to 10/31/2013 
 Mary Greeley Medical Center, Ames, IA 
o Reported a coverage rate of 93% from 1/1/2013 to 12/31/2013 
 
The Hepatitis B Birth Dose Honor Roll was created in July of 2013 to recognize hospitals and birth centers who 
achieved 90% or greater coverage rate of administering hepatitis B vaccine prior to discharge.  To protect 
newborns from hepatitis B viral infection, birthing institutions who qualify must also implement written 
policies, procedures, and protocols including: 
 A standing order to administer the hepatitis B vaccine to all infants is included as a part of 
routine newborn admission orders. 
 All newborns routinely receive hepatitis B vaccine after birth, prior to discharge. 
 Mother’s HBsAg screening test result is reviewed, and original result is included in her chart as 
well as in infant’s chart. 
 If incorrect test was ordered or is missing, an HBsAg blood test is ordered ASAP on the mother. 
 Infants born to HBsAg-positive mothers receive hepatitis B immune globulin (HBIG) and 
hepatitis B vaccine within 12 hours of birth. 
 Notification to the state or county health department’s perinatal hepatitis B prevention 
program prior to discharge for all mothers whose HBsAg test result is positive. 
 Infants born to mothers whose HBsAg status is unknown receive hepatitis b vaccine within 12 
hours of birth. 
 Infants who weigh less than 2000 grams who are born to mothers whose HBsAg status is 
unknown receive HBIG within 12 hours of birth. 
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Receiving and Unpacking Vaccine Shipments 
Vaccines must be stored appropriately from the time they are manufactured until the time they are 
administered to a patient.  Excessive heat or cold can reduce vaccine potency, increasing the risk recipients 
will not be protected against vaccine-preventable diseases.  All staff members (including non-medical staff, 
e.g., receptionists and other front desk personnel) who accept vaccine deliveries must be aware of the 
importance of maintaining the vaccine cold chain.  
 
Upon receipt of a VFC vaccine shipment, providers must open and examine the vaccine package immediately:  
  Review cold and heat indicators immediately to ensure vaccine was maintained at the appropriate 
temperatures during shipping.  
 Compare the vaccine received with the vaccine products that appear on the packing list.  Match the 
vaccine type, number of doses, lot number and expiration date to the vaccine invoice.   
  Immediately store vaccine at appropriate temperatures. 
 Accept VFC vaccine orders in IRIS.  Instructions can be found on the VFC web page at:  
http://www.idph.state.ia.us/ImmTB/Immunization.aspx?prog=Imm&pg=Vfc  
 Maintain vaccine packing slips for both VFC and private vaccine inventory for a minimum of three years. 
 
If there are problems with the temperature monitors or discrepancies with the packing slip, immediately 
notify the Iowa Vaccines for Children (VFC) Program at 1-800-831-6293.  Notification must occur on the same 
day the vaccine arrived at the provider’s office as documented by the carrier.   
 
Any questions regarding this requirement should be referred to Janean Iddings at 800-831-6293, ext. 5 or Tina 
Patterson at ext. 4. 
 
 
Required VFC Annual Training 
The CDC requires participating VFC program providers (primary and secondary VFC contacts) to complete 
annual training covering all VFC program requirements.  Additionally, annual training is recommended 
for any staff receiving and handling VFC vaccines to ensure understanding of storage and handling 
protocols.  Completion of the CDC web-based modules, You Call the Shots, will satisfy this training 
requirement.  Continuing education credit and certificates of completion are available with both modules. 
 
The training is available at http://www.cdc.gov/vaccines/ed/youcalltheshots.htm.  The two modules listed 
below must be completed prior to annual VFC re-enrollment: 
1.  Vaccine Storage and Handling-2014  
2.  Vaccines for Children (VFC)-2014  
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Q:  How many vaccines can be given during a visit? 
A: No upper limit exists for the number of vaccines that may be administered during one visit.  The 
Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP) 
consistently recommend all needed vaccines should be administered during an office visit. 
 
Q:  Please clarify how to determine the minimum interval or age for administering vaccines. 
Recommendations are sometimes written in months, weeks, or days.  
A: Recommendations are often written with different time intervals.  If the dosing interval is 4 months or 
more, a calendar month should be used to determine the minimum interval (e.g., October 1 to April 1 is 6 
months).  If the interval is less than 4 months, convert months into days or weeks (e.g., 1 month = 4 weeks 
= 28 days).  
 
Q:  What does "simultaneous administration of vaccines" mean?  Does it mean the same day?  
A: Simultaneous means the same day or the same clinic day.  If a patient receives a vaccine in the 
morning and then another the same afternoon, it would be considered simultaneous administration.  
 
Q:  Is it safe to administer a vaccine directly into an area where there is a tattoo? 
A: Both IM and SC vaccines may be given through a tattoo.  
 
Q:  Why do I sometimes get the message that a varicella or MMR dose is INVALID in IRIS when it was given 
on or after the first birthday? 
A:   In IRIS, when the blue hyperlink next to the invalid dose is selected it will provide an Explanation of 
Status.  The most common reason for this message is the administration of a dose of MMR or varicella 
within 28 days of another live virus vaccine.  The General Recommendations on Immunization states, to 
minimize the potential risk for interference, injectable or nasally administered live vaccines not 
administered on the same day should be administered greater than or equal to 4 weeks apart.  If injectable 
or nasally administered live vaccines are separated by less than 4 weeks, the second vaccine administered 
should not be counted as a valid dose and should be repeated.  The repeat dose should be administered 
greater than or equal to 4 weeks after the last invalid dose. 
  
 
 
New IRIS Password Requirements 
In the interest of protecting health information and unintended access to IRIS, IDPH will strengthen the 
security requirements of IRIS passwords.  The new IRIS password requirements, which are consistent with the 
State of Iowa security standards, are as follows: 
1. Passwords must be at least eight (8) characters  
2. Passwords must contain a mixture of numbers, upper case letters, and lower case letters  
3. Passwords must include at least one (1) special character  
4. Passwords must be changed at least every sixty days  
 
Effective May 7, 2014, IRIS passwords must meet these requirements.  Please call the IRIS Help Desk at 800-
374-3958 with questions about IRIS.  
  
Question Corner 
IRIS Update 
 Iowa Department of Public Health, Immunization Program Email Lists  
The Iowa Immunization Program has several email list serves available to help health care providers receive 
important and timely immunization related information.  Providers can send a blank email to the addresses 
below to receive updates directly in their inbox.  
 Vaccines for Children Program (VFC) List: join-VFC@lists.ia.gov 
 Immunization Program List: join-IMMUNIZATION@lists.ia.gov  
 Immunization Registry Information System (IRIS) List: join-IRISUSERS@lists.ia.gov  
 
 
Pneumococcal Conjugate (Prevnar) Chart 
The Pneumococcal Conjugate Vaccine Chart provides recommendations for children with a lapse in 
recommended vaccine series.  The chart was changed to updated recommendations for children 7 through 11 
months who had previously received 1 dose of vaccine.  Please discard old copies of the Prevnar Chart and 
replace them with the current version (4/14).  The chart is included on the following page and also available 
here. 
 
 
 
Resources  
2013 Immunization Program Annual Report 
The 2013 Immunization Program Annual Report is now available.  The report provides a summary of the 
activities and achievements of the Immunization Program and Iowa health care providers during the 
2013 calendar year.  The report includes sections on Funding, Special Projects, Immunization Registry 
Information System (IRIS), Vaccines for Children Program (VFC), Perinatal Hepatitis B, and Immunization 
Assessments.  The report serves as an informational resource for stakeholders, local partners, policy 
makers and the general public.  Click here to view the full report. 
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Recommended Regimen for Pneumococcal Conjugate Vaccine  
Among Children With a Lapse in Vaccine Administration 
 
How to use this chart: 
1. Locate the child’s age in the left column. 
2. In the row with the child’s age, locate the number of previous doses of PCV received. 
3. The corresponding cell to the right of the number of previous doses in the “recommended regimen” column provides 
the recommended total number of doses for the child.  
 
Child’s age now Previous Pneumococcal Conjugate Vaccination Recommended Regimen 
Total 
Doses in 
the Series 
 
2 through 6 
months 
0 doses  Give 3 doses at least 8 weeks apart. The 4th dose will be given at 12-15 months as the final dose 4 
1 dose Give 2 doses at least 8 weeks apart. The 4th dose will be given at 12-15 months as the final dose 4 
2 doses Give 1 dose. The 4th dose will be given at 12-15 months as the final dose 4 
 
7 through 11 
months 
0 or 1 dose 
Give 2 doses at least 4 weeks apart, 3rd or 4th 
dose given at 12-15 months as the final dose (at 
least 8 weeks later) 
3 or 4 
2 doses before age 7 months 
Give 1 dose at 7-11 months, with another dose 
given at 12-15 months as the final dose (at least 8 
weeks later)   
4 
 
12 through 23 
months 
0 doses Give 2 doses at least 8 weeks  apart as the final dose 2 
1 dose before age 12 months Give 2 doses at least 8 weeks apart as the final dose 3 
2 doses before age 12 months Give 1 dose at least 8 weeks after the most recent dose as the final dose 3 
1 dose on or after age 12 months Give 1 dose at least 8 weeks after the most recent dose as the final dose 2 
 
24 through 59 
months 
 
 
No previous doses Give one dose as the single and final dose  1 
If 1, 2 or 3 doses before 12 months Give 1 dose at least 8 weeks after the most recent dose as the final dose 2, 3, or 4 
If 1 dose between 12-23 months Give 1 dose at least 8 weeks after the most recent dose as the final dose 2 
If 2 doses between 12-23 months 
(separated by at least 8 weeks)   No additional doses.  Child is complete. 2 
If 1, 2, or 3 doses before 12 months 
and 1 dose between 12-23 months 
(separated by at least 8 weeks)  
No additional doses.  Child is complete. 2, 3, or 4 
If 1 dose after 24 months  No additional doses.  Child is complete. 1 
o For children with underlying medical conditions, a supplemental PCV13 dose is recommended.  For a list of conditions and 
recommendations, see the Morbidity Mortality Weekly Report (MMWR), Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-
Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6-18 Years with Immunocompromising Conditions: 
Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013, available at 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6225a3.htm and MMWR, Prevention of Pneumococcal Disease Among Infants 
and Children – Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine: 
Recommendations of the ACIP, 2010 available at http://www.cdc.gov/mmwr/pdf/rr/rr5911.pdf.  
o Infants and children who began immunization with PCV7 may complete series by switching to PCV13 at any point in the 
immunization schedule. 
o Children who have completed the infant series with PCV7 (4 doses of PCV7 or other age-appropriate complete PCV7 schedule) 
should be administered a single PCV13 dose prior to turning 5 years of age.    
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